Leo Medical

Leo Medical (乐奥医疗) is a Chinese minimally invasive medical device company in FreeS Fund's portfolio, focused on digestive endoscopy, peripheral vascular, and respiratory interventional therapies . Its peripheral vascular devices have broken international monopolies in that category, and the company has achieved "international firsts" across peripheral, digestive, and respiratory intervention fields, per a 2021 FreeS Fund year-in-review . Co-founder Zhang Zhongmin was featured in a 2022 FreeS Fund piece on women entrepreneurs, where she described Leo Medical as "a medical technology company born for innovation" aiming to "make impossible surgeries possible and complex surgeries simple" . The company's products target a gap Zhang identified in China's global standing in medical devices . elsewheres corpus does not cover more recent developments beyond this 2021-2022 timeframe.